Revealed aspect of metabolic osteoarthritis
- PMID: 27453640
- PMCID: PMC4941202
- DOI: 10.1016/j.jor.2016.06.029
Revealed aspect of metabolic osteoarthritis
Abstract
In current scenario there is an emerging trend to consider osteoarthritis (OA) phenotypes based on their risk factors and therefore offering potential for targeted therapies. OA prevalence with other coexistence diseases, such as systemic arterial hypertension, cardiovascular disease, diabetes, and dyslipidemia are increasing. Majority of OA associated with MetS, despite overweight of patients, the occurrence of OA in joints do not bear load suggest, the chronic inflammation status existing in patients with MetS can alter the metabolism of cartilage, regardless of excessive weight. This paper indicates that factors responsible for metabolic syndrome has clear role in cartilage degeneration and further degradation.
Keywords: Metabolic osteoarthritis; Metabolic syndrome; Osteoarthritis.
References
-
- Callaghan J.J. Lippincott Williams & Wilkins; Philadelphia: 2003. The Adult Knee.
-
- Lawrence R.C., Helmick C.G., Arnett F.C. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778–799. - PubMed
-
- Engström G., Gerhardsson de Verdier M., Rollof J., Nilsson P.M., Lohmander L.S. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthr Cartil. 2009;17(2):168–173. - PubMed
-
- Iannone F., Lapadula G. Obesity and inflammation – targets for OA therapy. Curr Drug Targets. 2010;11(5):586–598. - PubMed
-
- Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(January (3)):356–359. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
